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Brief Definitive Report
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The thymus is a central lymphoid organ for the differentiation of T cells . The
thymus contains >95% thymocytes and trace numbers of other cells like macrophages,
dendritic cells, and epithelial cells (1) . Only a small number of Ig+ B cells are de-
tected in normal thymi (1), but expanded numbers have been reported during dis-
ease . B cell follicles and numerous plasma cells have been reported in the thymus
of patients with autoimmune diseases like myasthenia gravis and systemic lupus
erythematosus (2-4), and similar findings have been noted in autoimmune-prone
mice such as (NZB x NZW)Fi, MRL/Mp-lpr/lpr (MRL/lpr), and BXSB (5) . In
these pathologic situations, it has not been elucidated if the B cells infiltrate the thymus
from the blood, or if the B cells originally are present in the thymus and expand
as part of the disease .
We have begun a study of thymic B cells to determine their contribution to au-
toantibody formation . We have succeeded in enriching thymic B cells from normal
mice and find that most of these lymphocytes have the unusual phenotype of the




Female (BALB/c x DBA/2)F, (CD2F,) and C57BL/6J (B6) mice were purchased
from Japan Clea Corp. (Tokyo) and kept under specific pathogen-free conditions until use
at 6-8 wk of age .
Antibodies. mAb to Thy-1.2 [F7D5] was purchased from Olac Ltd . (Bicester, United
Kingdom). mAb to Thy-1.2 (30-H12, IgG2b), CD4 (GK 1.5, IgG2b), Lyt-2 .2 or CD8 (HO-
2.2, IgM), B220 or CD45R (RA3-3A1/6.1, IgM; 14-8, IgG2b), Ia (M5/114 .15 .2, IgG2b),
and Mac-1 or CDllb (Ml/70, IgG2b) were from the American Type Culture Collection (Rock-
ville, MD) . The mAbs were used for depletion or staining. FITC-coupled rabbit anti-mouse
This work was supported in part by a grant from the Japanese Ministry of Health and Welfare, a grant
from the Naito Foundation, a grant from the Mitsubishi Foundation, and by a grant-in-aid from the
Mochida Memorial Foundation for Medical and Pharmaceutical Research, a grant from Suzuken
Memorial Foundation, the Science Research Promotion Fund of the Japan Private School Promotion
Foundation (1987), by a grant-in-aid for cancer research 62015088 from the Ministry ofEducation, Science
and Culture (1987), and by grants AG-03592, AG-05628, AG-05633, AI-19495, and AI-13013 from the
National Institutes of Health .
J. Exp. MED. © The Rockefeller University Press - 0022-1007/88/08/0811/06 $2.00 811







niversity user on 20 July 2020
812
	
MIYAMA-INABA ET AL . BRIEF DEFINITIVE REPORT
p-chain F(ab')2 or FITC-rabbit anti-mouse Ig F(ab')2 fragments were obtained from Cappel
Laboratories (West Chester, PA), while biotinated mouse anti-rat Igic mAb was from Zymed
Laboratories (San Francisco, CA) . Biotinated anti-Lyt-1 or CD5 (53 .7 .3, IgG2a), biotin-anti-
CD8 (53.6 .7, IgG2a), FITC-avidin, and PE-avidin were from Becton Dickinson & Co. (Moun-
tain View, CA) . F(ab')2 fragment of goat anti-mouse p chain from Cappel Laboratories was
used to stimulate B cells .
Cell Preparation . The connective tissue attached to thymic lobes was carefully peeled off
to remove the parathymic lymph nodes . Thymocytes were prepared by gentle teasing onto
a fine steel mesh, were washed twice in RPMI 1640 medium (Nissui, Tokyo, Japan), and
suspended in medium with 10% FCS (HyClone Laboratories, Logan, UT) . Cell suspensions
were layered onto the 65% Percoll solution (Pharmacia Fine Chemicals, Uppsala, Sweden)
(1) and centrifuged at 900 g for 20 min . The low-density cells (50-60% of the total) at the
interface between the medium and the Percoll solution were collected, washed twice in RPMI
1640, and treated with a mixture ofmAb to Thy-1 .2, CD4, and CD8 (above) in the presence
of rabbit complement . The mAb and dead cells were removed by washing twice in alkaline
(pH 7 .6-7 .8) RPMI 1640 . The resulting population was B cell enriched and T cell depleted
(see Results) . B cells from the spleen were prepared by the same T cell depletion procedure,
with or without passage through Sephadex G10 .
Proliferative Assays . Triplicate cultures of 10' cells were incubated in 0.2 ml of RPMI 1640
medium containing 10% FCS, penicillin, streptomycin, and 50 pM 2-ME in flat-bottomed
Corning microculture plates . The stimuli were : 25 pg/ml LPS (Escherichia coli 055:85 Difco
Laboratories Inc ., Detroit, MI), 2 pg/ml Con A (Pharmacia Fine Chemicals), or anti-p (10
pg/ml) plus rIL-4 or purified BSF-1 (generously donated by Dr. T. Honjo, Kyoto University,
and Dr. K . Kumagai, Tohoku University) . Proliferation was measured on the third day by
pulsing with 1 gCi of [ 3H]thymidine for 10 h .
Cytofuorography. Cells were suspended in PBS with 2% FCS and 0.05% azide and stained
according to a triple-layer method using rat mAb, biotin-mouse anti-rat Igic, and FITC-avi-
din . The controls were stained with FITC- or PE-avidin without first mAb, or with nonreac-
tive, isotype-matched mAb (see Results) . To double label for Ly-1 and surface Ig, the cells
were stained first with FITC-rabbit anti-mouse g chain F(ab')2 fragment followed by normal
rat Ig to block the reactivity of anti-p with the subsequent antibody and to reduce binding
to Fc receptors . Then the cells were stained with biotin-anti-Ly-1 and PE-avidin . Nonreac-
tive control biotin-mAb were to Thy-1 and CD8. The cells were analyzed on a FACStar (B-D
Automated Immunochemistry, Salt Lake City, UT) .
Results
Enrichment ofB Cellsfrom Normal Thymus . To enrich the trace population ofthymic
B cells, suspensions were separated on Percoll density gradients . Most sIg+ thymic
B cells were recovered in the low-density fraction, whereas only a supopulation of
splenic B cells floated under similar conditions . After treatment with a cocktail of
anti-T cell mAb and complement, the frequency of sIg+ B cells rose from -3% to
>90°/ (below) . The yield was N1% of the starting thymus suspension .
B cell enrichment was evident by functional assays, i .e ., proliferation to LPS and
anti-p plus IL-4 . The starting thymocytes, the low-density fraction, and the B cell-en-
riched population were compared (Table I) . The latter responded best to LPS, and
to anti-g plus IL-4, but was depleted of Con A reactivity. The low-density cells
(50-60% of the total thymus cells) responded vigorouly to Con A because most im-
munoincompetent thymocytes sedimented (not shown), but weakly to LPS and IL-
4 . The high-density population, even when treated with anti-T cell mAb and com-
plement, failed to respond to the B cell stimuli (not shown) .
Phenotype ofThymic B Cells. Cytofluorography was used to compare enriched prepa-
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* Cells (10) were cultured with or without various kinds of stimulants for 72 h, and pulsed with t3H)TdR
for the last 10 h of the culture period . Numbers in the table represent mean cpm of triplicated cultures .
Cells in each fraction were stained with FITC-conjugated rabbit anti-mouse Ig antibody .
4 Low-density cells were obtained from the upper layer of the 65% Percoll gradient .
~~ B cell-enriched cells were obtained form the low-density cells by treating them with anti-L3T4, anti-Lyt-2 .2,
and anti-Thy-1 .2 mAbs plus complement .
thymic B cells coexpressed Lyt-1 (CD5), whereas most splenic B cells were Lyt-1 - .
The thymic B cells could also be killed with a cytotoxic anti-Lyt-1 mAb (not shown) .
Both thymic and splenic B cells had comparable levels of sIg (Fig . 2, a andf), but
most of the thymic B cells had less B220 or CD45R (b vs . g) and la (c vs . h) . Mac-1
[CDllb] and CD5 were found on most thymic B cells, which did not react with two
isotype-matched control mAbs, GK1.5 anti-CM and 30-H12 antiThy-1 (d and e) .
Discussion
We have been able to enrich the small number of thymic B cells (N 1 % of thymic
suspensions) and have found that most have the features of Ly-1 B cells . The latter
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TABLE I
Enrichment of Thymic B Cells
Thymic B cells Splenic B cells
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FIGURE 1 . Two color FRCS analysis of thymic and splenic B cells. Enriched populations ofthymic
and splenic B cells were treated successively with FITC-rabbit anti-mouse R chain F(ab')z frag-
ment, excess normal rat IgG, biotin-anti-Lyt-I (CD5), and PE-avidin . The stained cells were























Total cells 892 573 1,574 1,261 643 13,883 0.6
Low-density cellsS 914 577 4,360 3,492 284 71,091 2.7
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FIGURE 2 . Phenotype of thymic and Splenic B cells . Enriched populations of thymic (tofu) and
splenic (bottom) B cells were stained with the different mAbs indicated on the panel and specified
in Materials and Methods, followed by biotin-mouse anti-rat Igic and FITC-avidin . The desig-
nation [-] on the panels were controls that were unstained cells (a andf), FITC-avidin only (b
and g), and biotin-mouse anti-rat Igic and FITC-avidin (e ands) .
are a distinct population of CD11b' and CD5' lymphocytes which are detected in
the peritoneal cavity but are hard to find in spleen, blood, and especially lymph
nodes (6, 7) . Similar results were obtained with thymi of C57BL/6 and young NZB
mice, andfrom C57BL/6 mice varying in age from 3 to 8wk (not shown). Thestaining
of B cells for CD5 was specific, since no decrease was seen with an excess of rat Ig
(500 wg/ml) to block Fc receptors, and there was no staining with other anti-T cell
mAbs like antiThy-1 CD8 and CD4. Furthermore, the majority of thymic B cells
prepared by ourprocedure could be killed by anti-CD5 (but not antiThy-1.2, CD4,
or CD8) mAb and complement . Other comparisons with conventional splenic B
cells are that the thymic cells had less B220 and la antigens, a lower buoyant density
in Percoll, and similar amounts of membrane g . These results are consistent with
those reported for Ly-1' B cells in the peritoneal cavity (8, 9) .
Our functional assays demonstrated that thymic B cells responded to B cell
stimulants . However, the responses were much lower than spleen (not shown) . In
preliminary studies, Ly-1' thymic B cells have been purified on the FACS and found
to have little or no responsiveness either to LPS or to anti-w and IL-4 . Likewise,
depletion with anti-Ly-1 and complement enhances the responsiveness of the thymic
B cell preparation to these stimuli. Therefore Ly-1 B cells may not contribute to
the functional assays that were used to help monitor ourenrichment method (Table I) .
Peripheral Ly-1' B cells are known to be involved in "spontaneous" secretion of
IgM, including autoreactive antibody (10) . These B cells appear early in develop-
ment (11) and are long lived (12) . A regulatory role has been suggested in allotypic
(13) and idiotypic cell-cell interactions (14-16). This being the case, it is possible
that the Ig V region of thymic Ly-1 B cells shapes the repertoire of T cell antigen
receptors by providing epitopes that correspond to antigen in association with self-
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MHC. Alternatively, products of the Ly-1 B cell repertoire may function to elimi-
nate or inactivate self-reactive T cells by providing internal images of self during
T cell development . We are now studying the ontogeny of these thymic B cells to
clarify their function in normal and autoimmune-prone mice .
Summary
A small number of B cells are found in the thymus of normal mice . A population
of B lymphocytes could be enriched to >90% purity by isolating a low-density frac-
tion on Percoll density gradients and then depleting T cells with a mixture of anti-
Thy-1, CD4, and CD8 mAbs and complement . Enrichment was monitored by sur-
face Ig staining and by functional studies (responsiveness to LPS, and to anti-w plus
IL-4) . When the phenotype of these B cells was studied by flow cytometry, 60-80%
had the phenotype Ly-1+ (CD5), la', B220' (CD45R), and Mac-1' (CD Ilb) . In
contrast, splenic B cells lacked CD5 and CD11b and expressed higher levels of B220
and Ia antigens . These results indicate that most thymic B cells have the phenotype
of the Ly-1 B cell subset, which was identified previously as a trace subpopulation
in some peripheral tissues and is thought to play a role in autoantibody formation .
The authors express their gratitude to Ms. K . Higuchi and Ms . K . Nomura for technical
assistance, Ms . S . Ohya for manuscript preparation, and Mr. K. Kobayashi, Research Center
of Kansai Medical University for the FAGS studies .
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